|
2025
|
G/S
|
Pharmaceutical research and development |
|
2024
|
G/S
|
Pharmaceutical research and development. Licensing of pharmaceutical products. |
|
|
G/S
|
Solubilizing chemical agents for use in the manufacture of
pharmaceutical preparations; solubili... |
|
|
G/S
|
Solubilizing chemical agents for use in the manufacture of pharmaceutical preparations; Solubiliz... |
|
|
G/S
|
Pharmaceutical research and development Licensing of pharmaceutical products |
|
2023
|
Invention
|
Topical antiviral compositions, delivery systems, and methods of using the same. The present inve... |
|
2022
|
Invention
|
Nitric oxide-releasing nasal compositions and methods of use thereof.
The present invention rela... |
|
|
Invention
|
Cyclic phosphoramidate compounds.
Provided herein are cyclic phosphoramidate compounds, their pr... |
|
|
Invention
|
Cyclic phosphoramidate compounds. Provided herein are cyclic phosphoramidate compounds, their pre... |
|
|
Invention
|
Nucleotide prodrug compounds. Provided herein are nucleotide prodrug compounds, their preparation... |
|
|
Invention
|
Unnatural configuration nucleotide prodrug compounds.
Provided herein am phosphoramidate and cyc... |
|
|
Invention
|
Unnatural configuration nucleotide prodrug compounds. Provided herein are phosphoramidate and cyc... |
|
|
G/S
|
Pharmaceutical research and development of a process to
deliver pharmaceutical preparations. |
|
|
Invention
|
Topical compositions and methods of using the same.
The present invention relates generally to c... |
|
2021
|
Invention
|
Heterocycle amines and uses thereof. Compounds and methods in the fields of chemistry and medicin... |
|
|
Invention
|
Antiviral prodrug compounds.
Provided herein are nucleotide prodrug compounds, their preparation... |
|
|
Invention
|
Antiviral prodrug compounds. Provided herein are nucleotide prodrug compounds, their preparation ... |
|
|
Invention
|
Tunable nitric oxide-releasing macromolecules having multiple nitric oxide donor structures.
Pro... |
|
|
G/S
|
Pharmaceutical research and development
Licensing of pharmaceutical products |
|
|
Invention
|
Benzyloxy phosph(on)ate compounds.
Provided herein are 2-substituted benzyloxy phosph(on)ate com... |
|
|
Invention
|
Benzyloxy phosph(on)ate compounds. Provided herein are 2-substituted benzyloxy phosph(on)ate comp... |
|
2020
|
Invention
|
Imidazo-fused heterocycles and uses thereof. Compounds and methods in the fields of chemistry and... |
|
|
Invention
|
Selective androgen receptor modulators (sarms) and uses thereof. Provided herein are compounds, s... |
|
|
Invention
|
Methods and compositions associated with the granulocyte colony-stimulating factor receptor. Some... |
|
|
Invention
|
Cyclic phosphate compounds.
Provided herein are cyclic phosphate compounds, their preparation an... |
|
|
Invention
|
Cyclic phosphate compounds. Provided herein are cyclic phosphate compounds, their preparation and... |
|
|
Invention
|
Crystalline forms and methods of producing crystalline forms of a compound. Disclosed herein are ... |
|
2019
|
Invention
|
Topical compositions.
Provided herein are anhydrous compositions that include at least one visco... |
|
|
G/S
|
Pharmaceutical research and development of a process to deliver organ specific pharmaceutical pre... |
|
|
G/S
|
Pharmaceutical research and development of a process to
deliver organ specific pharmaceutical pr... |
|
|
Invention
|
Methods and compositions for modulating hormone levels. Provided herein are compositions and meth... |
|
|
Invention
|
Prodrug compounds and their uses. Provided herein are prodrug compounds, their preparation and th... |
|
|
Invention
|
Tunable nitric oxide-releasing macromolecules having multiple nitric oxide donor structures. Prov... |
|
|
Invention
|
Nitric oxide releasing suppositories and methods of use thereof. The present invention relates ge... |
|
|
Invention
|
Glucagon receptor antagonists. Provided herein are solid state forms of compounds, including enan... |
|
|
Invention
|
Topical compositions and methods of using the same. The present invention generally relates to to... |
|
|
Invention
|
Acetal compounds and therapeutic uses thereof. Disclosed herein are acetal and cyclic acetal comp... |
|
2018
|
Invention
|
Topical compositions. Provided herein are anhydrous compositions that include at least one viscos... |
|
|
Invention
|
Glucagon antagonists.
Provided herein are compounds, including enantiomerically pure forms there... |
|
|
Invention
|
Topical compositions and methods of using the same. The present invention relates generally to co... |
|
|
Invention
|
Prodrug compounds and uses thereof. Provided herein are cyclic phosphorus-containing prodrug comp... |
|
|
Invention
|
Method for treating chronic inflammatory diseases.
Methods of administering and pharmaceutical c... |
|
2017
|
Invention
|
Glucagon receptor antagonists.
Provided herein are compounds, including enantiomerically pure fo... |
|
|
Invention
|
Compositions, systems, kits, and methods for treating an infection. Tinea pedis) infection. |
|
|
Invention
|
Compositions for treating inflammation and methods of treating the same. Provided herein are comp... |
|
2016
|
G/S
|
Licensing of pharmaceutical products |
|
2001
|
G/S
|
Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use... |
|
1995
|
G/S
|
Medicines for the treatment of cancer conditions.
Medicines for the treatment of cancer and pre-c... |
